New insights around respiratory infectious disease rely on robust real-world data
Efforts to understand SARS-CoV-2 and the implications for transmission and clinical manifestations have taught us the importance of analyzing viral genome sequence data in combination with patient clinical and genomic data. Knowledge about infectious disease severity and susceptibility is reliant on data that provides a complete picture.
Our diverse network of diagnostic labs are frequently testing for respiratory pathogens and contributing consented, de-identified samples and data to Ovation’s database.
Diverse US Coverage
Sourced from labs across the country. Ovation data represents an array of patients from diverse racial and ethnic backgrounds.
Exclusive Ovation Network
Enhance your analyses with Ovation lab testing data which is not found in other data sources outside the Ovation UMS network.
Consent at Every Step
Testing samples are consented and de-identified for research purposes as part of the clinical workflow ensuring patient privacy and easy access to the data for your bioinformatics team.
275+ Pathogens Available
Extensive distribution across therapeutic areas, including COVID-19, influenza, respiratory syncytial virus & more